X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-16 | TG | Tredegar Corp | Gottwald James T. | 10% | S - Sale | $8.57 | -13,887 | 1,707,553 | -1% | -$119,053 | ||||||
2026-01-16 | TG | Tredegar Corp | Gottwald John D | 10% | S - Sale | $8.57 | -13,887 | 3,588,146 | 0% | -$119,053 | ||||||
2026-01-16 | TG | Tredegar Corp | Gottwald William M | 10% | S - Sale | $8.57 | -13,886 | 1,785,011 | -1% | -$119,045 | ||||||
| D | 2026-01-16 | DAL | Delta Air Lines, Inc. | Snell Erik Storey | EVP, Chief Cust Exper Officer | S - Sale+OE | $71.02 | -39,420 | 35,625 | -53% | -$2,799,411 | |||||
2026-01-21 | ABEO | Abeona Therapeutics Inc. | Alvino Mark | Dir | S - Sale | $5.23 | -13,500 | 48,752 | -22% | -$70,574 | ||||||
| D | 2026-01-20 | GILD | Gilead Sciences, Inc. | Bluestone Jeffrey | Dir | S - Sale+OE | $123.50 | -5,000 | 8,920 | -36% | -$617,500 | |||||
| M | 2026-01-16 | VTS | Vitesse Energy, Inc. | Gerrity Robert W | CEO | S - Sale | $19.44 | -113,708 | 1,199,164 | -9% | -$2,210,504 | |||||
| D | 2026-01-20 | HIMS | Hims & Hers Health, Inc. | Okupe Oluyemi | CFO | S - Sale+OE | $30.34 | -9,067 | 99,470 | -8% | -$275,114 | |||||
| M | 2026-01-16 | VTS | Vitesse Energy, Inc. | Cree Brian | Pres | S - Sale | $19.36 | -39,264 | 464,225 | -8% | -$760,291 | |||||
| M | 2026-01-16 | TSQ | Townsquare Media, Inc. | Hellum Erik | COO | S - Sale | $5.55 | -13,959 | 969,648 | -1% | -$77,529 | |||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Baumal Caroline | Chief Medical Officer | S - Sale | $19.79 | -1,882 | 89,324 | -2% | -$37,250 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Chopas James George | VP, Chief Accounting Officer | S - Sale | $19.79 | -726 | 51,869 | -1% | -$14,370 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Delong Mark Jeffrey | Chief Business, Strat Officer | S - Sale | $19.79 | -1,334 | 81,724 | -2% | -$26,404 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | S - Sale | $19.79 | -909 | 1,157,310 | 0% | -$17,992 | ||||||
2026-01-16 | FROG | Jfrog Ltd | Landman Yoav | CTO | S - Sale | $57.71 | -45,000 | 5,868,641 | -1% | -$2,596,950 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | CEO | S - Sale | $19.79 | -8,182 | 1,627,659 | -1% | -$161,946 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | S - Sale | $19.79 | -2,203 | 78,843 | -3% | -$43,604 | ||||||
2026-01-16 | FOA | Finance of America Companies Inc. | Thornock Tai A. | Chief Accounting Officer | S - Sale | $24.58 | -1,100 | 10,650 | -9% | -$27,038 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | CFO | S - Sale | $19.79 | -2,892 | 164,584 | -2% | -$57,241 | ||||||
| D | 2026-01-20 | EQH | Equitable Holdings, Inc. | Pearson Mark | Pres, CEO | S - Sale+OE | $46.20 | -39,700 | 652,945 | -6% | -$1,834,298 | |||||
| M | 2026-01-20 | IDCC | Interdigital, Inc. | Chen Lawrence Liren | Pres, CEO | S - Sale | $315.24 | -5,950 | 159,035 | -4% | -$1,875,678 | |||||
2026-01-16 | OFIX | Orthofix Medical Inc. | Andrews Julie | CFO | S - Sale | $14.38 | -4,873 | 58,039 | -8% | -$70,074 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Watson David O. | GC | S - Sale | $19.79 | -2,475 | 156,499 | -2% | -$48,987 | ||||||
| D | 2026-01-20 | TVTX | Travere Therapeutics, Inc. | Reed Elizabeth E | GC, GC | S - Sale+OE | $27.34 | -10,000 | 90,270 | -10% | -$273,420 | |||||
2026-01-20 | ACN | Accenture Plc | Clifford Katherine Lee | Chief Leadership, HR Officer | S - Sale | $280.63 | -681 | 6,815 | -9% | -$191,108 | ||||||
| D | 2026-01-20 | MIRM | Mirum Pharmaceuticals, Inc. | Quan Joanne | CHIEF MEDICAL OFFICER | S - Sale+OE | $90.27 | -6,911 | 11,305 | -38% | -$623,853 | |||||
2026-01-20 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $101.85 | -5,000 | 4,492,950 | 0% | -$509,225 | ||||||
2026-01-20 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Finance, Treasurer | S - Sale | $30.12 | -3,034 | 41,011 | -7% | -$91,384 | ||||||
2026-01-21 | DTI | Drilling Tools International Corp | Domino Michael Wayne Jr. | Pres, DTR Division | S - Sale | $4.00 | -24,996 | 1,433,054 | -2% | -$99,984 | ||||||
| D | 2026-01-16 | KRUS | Kura Sushi Usa, Inc. | Uba Hajime | SEE REMARKS (a) | S - Sale+OE | $72.93 | -9,874 | 6,026 | -62% | -$720,131 | |||||
| D | 2026-01-20 | VICR | Vicor Corp | D'Amico Andrew | Dir | S - Sale+OE | $155.00 | -200 | 0 | -100% | -$31,000 | |||||
2026-01-20 | JBHT | Hunt J B Transport Services Inc | Hobbs Nicholas | EVP, COO | S - Sale | $201.97 | -3,038 | 115,065 | -3% | -$613,582 | ||||||
2026-01-21 | XCUR | Exicure, Inc. | Exicure Hitron Inc. | 10% | S - Sale | $4.50 | -258,367 | 1,598,947 | -14% | -$1,162,652 | ||||||
2026-01-20 | SYNA | Synaptics Inc | Patel Rahul G. | See remarks below | S - Sale | $87.21 | -2,281 | 113,601 | -2% | -$198,925 | ||||||
2026-01-16 | DRI | Darden Restaurants Inc | Wilkerson John W. | Pres Elect, Olive Garden | S - Sale | $213.00 | -2,258 | 18,390 | -11% | -$480,954 | ||||||
| DM | 2026-01-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO | S - Sale+OE | $13.59 | -138,167 | 3,379,465 | -4% | -$1,878,094 | |||||
| DM | 2026-01-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-CEO | S - Sale+OE | $13.59 | -138,188 | 3,379,398 | -4% | -$1,877,570 | |||||
2026-01-15 | NRGV | Energy Vault Holdings, Inc. | Softbank Vision Fund (Aiv M2) L.P. | 10% | S - Sale | $5.65 | -3,000,000 | 15,535,631 | -16% | -$16,950,000 | ||||||
2026-01-15 | FBK | Fb Financial Corp | McPherson James Austin | 10% | S - Sale | $60.06 | -8,500 | 7,063,425 | 0% | -$510,510 | ||||||
2026-01-15 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale | $35.92 | -20,961 | 0 | -100% | -$752,833 | ||||||
| D | 2026-01-20 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | S - Sale+OE | $32.10 | -416 | 50,437 | -1% | -$13,354 | |||||
| D | 2026-01-15 | EXPO | Exponent Inc | Corrigan Catherine | Pres, CEO | S - Sale+OE | $72.52 | -1,663 | 92,723 | -2% | -$120,594 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Swayze Eric | EVP Research | S - Sale+OE | $75.34 | -9,933 | 42,253 | -19% | -$748,383 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $75.59 | -9,302 | 63,890 | -13% | -$703,138 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | O'Neil Patrick R. | EVP CLO, GC | S - Sale+OE | $75.84 | -9,191 | 66,171 | -12% | -$697,045 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Monia Brett P | CEO | S - Sale+OE | $74.82 | -44,034 | 224,683 | -16% | -$3,294,624 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Kordasiewicz Holly B. | EVP, Chief Development Officer | S - Sale+OE | $75.66 | -4,141 | 14,718 | -22% | -$313,308 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $75.96 | -1,823 | 16,389 | -10% | -$138,475 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale+OE | $75.22 | -12,922 | 126,307 | -9% | -$971,993 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Devers Shannon L. | EVP, Chief HR Ofc | S - Sale+OE | $75.95 | -8,353 | 26,518 | -24% | -$634,410 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $75.11 | -8,480 | 60,435 | -12% | -$636,933 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale+OE | $75.15 | -8,977 | 94,757 | -9% | -$674,622 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Baroldi Joseph | EVP, Chief Business Officer | S - Sale+OE | $75.75 | -8,056 | 45,203 | -15% | -$610,276 | |||||
| D | 2026-01-20 | ACLX | Arcellx, Inc. | Lubner David Charles | Dir | S - Sale+OE | $75.00 | -6,000 | 21,659 | -22% | -$450,000 | |||||
| D | 2026-01-20 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $18.42 | -3,760 | 50,897 | -7% | -$69,273 | |||||
| D | 2026-01-15 | RDDT | Reddit, Inc. | Huffman Steve Ladd | CEO, Pres, 10% | S - Sale+OE | $232.78 | -18,000 | 448,576 | -4% | -$4,190,055 | |||||
2026-01-16 | PLAB | Photronics Inc | Lee Kang Jyh | Dir | S - Sale | $34.51 | -10,000 | 410,850 | -2% | -$345,100 | ||||||
2026-01-15 | DBX | Dropbox, Inc. | Schubach Sarah Elizabeth | Chief Accounting Officer | S - Sale | $26.84 | -1,168 | 92,702 | -1% | -$31,349 | ||||||
2026-01-16 | ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Dir | S - Sale | $12.00 | -6,700 | 254,872 | -3% | -$80,431 | ||||||
2026-01-16 | SNAP | Snap Inc | Mohan Ajit | Chief Business Officer | S - Sale | $7.62 | -20,848 | 5,277,816 | 0% | -$158,953 | ||||||
2026-01-16 | NRDY | Nerdy Inc. | Paszterko John Andrew | COO | S - Sale | $1.01 | -18,457 | 581,543 | -3% | -$18,642 | ||||||
| D | 2026-01-16 | NBIX | Neurocrine Biosciences Inc | Gano Kyle | CEO | S - Sale+OE | $132.71 | -36,400 | 140,407 | -21% | -$4,830,458 | |||||
2026-01-20 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Finance | S - Sale | $4.86 | -1,581 | 84,081 | -2% | -$7,684 | ||||||
2026-01-20 | AURA | Aura Biosciences, Inc. | De Los Pinos Elisabet | See Remarks | S - Sale | $4.86 | -16,928 | 585,226 | -3% | -$82,270 | ||||||
2026-01-15 | META | Meta Platforms, Inc. | Kimmitt Robert M | Dir | S - Sale | $618.28 | -580 | 5,587 | -9% | -$358,602 | ||||||
| DM | 2026-01-08 | GKOS | Glaukos Corp | Burns Thomas William | COB, CEO | S - Sale+OE | $115.00 | -275,000 | 1,605,814 | -15% | -$31,625,000 | |||||
| D | 2026-01-20 | KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Dir | S - Sale+OE | $67.91 | -5,500 | 0 | -100% | -$373,521 | |||||
| D | 2026-01-16 | PTON | Peloton Interactive, Inc. | Kirol Charles Peter | COO | S - Sale+OE | $6.47 | -22,520 | 81,001 | -22% | -$145,650 | |||||
| M | 2026-01-13 | PLAB | Photronics Inc | Park Han Kyung | SVP, GM of FPD Ops | S - Sale | $34.24 | -13,750 | 75,500 | -15% | -$470,813 | |||||
2026-01-20 | MDGL | Madrigal Pharmaceuticals, Inc. | Kelley Shannon T | GC | S - Sale | $497.36 | -692 | 8,481 | -8% | -$344,173 | ||||||
2026-01-16 | LPSN | Liveperson Inc | Mina Christopher Allen | Chief Tech Product Officer | S - Sale | $3.15 | -7,152 | 52,636 | -12% | -$22,543 | ||||||
| M | 2026-01-15 | STSS | Sharps Technology Inc. | Saba Capital Management, L.P. | 10% | S - Sale | $2.32 | -37,182 | 1,511,988 | -2% | -$86,371 | |||||
2026-01-20 | MDGL | Madrigal Pharmaceuticals, Inc. | Taub Rebecca | Dir | S - Sale | $490.77 | -2,238 | 1,108,891 | 0% | -$1,098,343 | ||||||
2026-01-15 | IIF | Morgan Stanley India Investment Fund, Inc. | Saba Capital Management, L.P. | 10% | S - Sale | $24.36 | -7,490 | 938,726 | -1% | -$182,456 | ||||||
| D | 2026-01-16 | OS | Onestream, Inc. | Hohenstein Ken | Chief Revenue Officer | S - Sale+OE | $23.63 | -120,000 | 1,781,240 | -6% | -$2,835,600 | |||||
2026-01-15 | MEGI | Nyli Cbre Global Infrastructure Megatrends Term Fund | Saba Capital Management, L.P. | 10% | S - Sale | $13.88 | -40,916 | 5,202,343 | -1% | -$567,914 | ||||||
2026-01-15 | NKTX | Nkarta, Inc. | Hastings Paul J | CEO | S - Sale | $2.07 | -26,046 | 390,023 | -6% | -$53,915 | ||||||
2026-01-20 | CLOV | Clover Health Investments, Corp. /De | Reynoso Jamie L. | CEO, Medicare Advantage | S - Sale | $2.58 | -4,597 | 2,737,700 | 0% | -$11,860 | ||||||
2026-01-15 | NKTX | Nkarta, Inc. | Mahmood Nadir | Pres | S - Sale | $2.07 | -5,649 | 167,727 | -3% | -$11,693 | ||||||
2026-01-16 | JBL | Jabil Inc | Mondello Mark T | Exec COB | S - Sale | $250.00 | -17,200 | 1,111,459 | -2% | -$4,300,003 | ||||||
| DM | 2026-01-16 | AMPX | Amprius Technologies, Inc. | Sun Kang | Dir | S - Sale+OE | $11.06 | -993,733 | 1,677,926 | -37% | -$10,994,944 | |||||
2026-01-16 | JBL | Jabil Inc | Berry Adam E. | SVP, IR, Corporate Affairs | S - Sale | $253.20 | -1,596 | 18,920 | -8% | -$404,113 | ||||||
2026-01-15 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $21.05 | -10,156 | 616,885 | -2% | -$213,804 | ||||||
2026-01-15 | CHRW | C. H. Robinson Worldwide, Inc. | Short Michael John | Pres, Global Forwarding | S - Sale | $175.00 | -1,230 | 53,928 | -2% | -$215,250 | ||||||
| M | 2026-01-15 | ECAT | Blackrock Esg Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% | S - Sale | $15.96 | -155,887 | 26,070,901 | -1% | -$2,487,252 | |||||
2026-01-15 | AIP | Arteris, Inc. | Janac K Charles | Pres, CEO, 10% | S - Sale | $17.84 | -17,884 | 9,594,810 | 0% | -$318,974 | ||||||
2026-01-15 | AIP | Arteris, Inc. | Bayview Legacy, LLC | 10% | S - Sale | $17.84 | -17,884 | 9,399,071 | 0% | -$318,974 | ||||||
2026-01-16 | NFLX | Netflix Inc | Hyman David A | GC | S - Sale | $88.11 | -23,439 | 316,100 | -7% | -$2,065,206 | ||||||
2026-01-15 | CIFR | Cipher Mining Inc. | Kelly Patrick Arthur | Co-Pres, COO | S - Sale | $17.76 | -35,568 | 1,512,644 | -2% | -$631,688 | ||||||
| M | 2026-01-15 | PHR | Phreesia, Inc. | Vanduyn Amy Beth | SVP, HR | S - Sale | $16.36 | -2,889 | 157,349 | -2% | -$47,270 | |||||
| M | 2026-01-15 | PHR | Phreesia, Inc. | Roberts Evan | Pres, Provider Solutions | S - Sale | $16.36 | -8,078 | 826,554 | -1% | -$132,171 | |||||
| M | 2026-01-15 | PHR | Phreesia, Inc. | Linetsky David | Pres, Network Solutions | S - Sale | $16.36 | -7,781 | 233,731 | -3% | -$127,312 | |||||
| M | 2026-01-15 | PHR | Phreesia, Inc. | Indig Chaim | CEO | S - Sale | $16.36 | -12,633 | 1,616,535 | -1% | -$206,704 | |||||
| M | 2026-01-15 | PHR | Phreesia, Inc. | Hoffman Allison C | GC, Secretary | S - Sale | $16.36 | -5,101 | 169,661 | -3% | -$83,461 | |||||
| M | 2026-01-15 | PHR | Phreesia, Inc. | Gandhi Balaji | CFO | S - Sale | $16.36 | -5,662 | 150,569 | -4% | -$92,634 | |||||
2026-01-05 | SEZL | Sezzle Inc. | Brehm Kyle M. | Dir | S - Sale | $65.55 | -1 | 24,128 | 0% | -$66 | ||||||
2026-01-15 | BETR | Better Home & Finance Holding Co | Smith Chad M. | Pres, COO, Better Mortgage | S - Sale | $36.70 | -6,000 | 21,590 | -22% | -$220,221 | ||||||
| M | 2026-01-15 | JOE | St Joe Co | Berkowitz Bruce R | 10% | S - Sale | $65.51 | -101,600 | 16,757,990 | -1% | -$6,655,677 | |||||
2026-01-16 | RPRX | Royalty Pharma Plc | Urist Marshall | EVP, Research, Investments | S - Sale | $39.52 | -20,000 | 66,418 | -23% | -$790,346 | ||||||
| D | 2026-01-16 | AZO | Autozone Inc | Smith Richard Craig | SVP | S - Sale+OE | $3,500.00 | -3,190 | 2,627 | -55% | -$11,165,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |